[go: up one dir, main page]

DK0670904T3 - Vector for expression of therapeutically relevant genes - Google Patents

Vector for expression of therapeutically relevant genes

Info

Publication number
DK0670904T3
DK0670904T3 DK94900042T DK94900042T DK0670904T3 DK 0670904 T3 DK0670904 T3 DK 0670904T3 DK 94900042 T DK94900042 T DK 94900042T DK 94900042 T DK94900042 T DK 94900042T DK 0670904 T3 DK0670904 T3 DK 0670904T3
Authority
DK
Denmark
Prior art keywords
vector
expression
therapeutically relevant
relevant genes
gene
Prior art date
Application number
DK94900042T
Other languages
Danish (da)
Inventor
Ulrike Stein
Wolfgang Walther
Original Assignee
Max Delbrueck Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum filed Critical Max Delbrueck Centrum
Application granted granted Critical
Publication of DK0670904T3 publication Critical patent/DK0670904T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

The object of the invention is to render cancer therapy more effective, thus more successful. This object is reached by means of a vector for the expression of therapeutically relevant proteins based on constructs which are suitable for expression im mammal cells. This vector is characterized by a mdr1 promoter inducible by cytostatic agents or a defined sequence thereof, by a gene for coding a therapeutically relevant protein and possibly by mdr1 enhancer elements arranged before of after the gene.
DK94900042T 1992-11-12 1993-11-10 Vector for expression of therapeutically relevant genes DK0670904T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4238778A DE4238778C2 (en) 1992-11-12 1992-11-12 Vector for the expression of therapeutically relevant genes
PCT/DE1993/001086 WO1994011522A2 (en) 1992-11-12 1993-11-10 Vector for the expression of therapy-relevant genes

Publications (1)

Publication Number Publication Date
DK0670904T3 true DK0670904T3 (en) 2003-07-14

Family

ID=6473100

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94900042T DK0670904T3 (en) 1992-11-12 1993-11-10 Vector for expression of therapeutically relevant genes

Country Status (6)

Country Link
EP (1) EP0670904B1 (en)
JP (1) JPH09504161A (en)
AT (1) ATE234929T1 (en)
DE (2) DE4238778C2 (en)
DK (1) DK0670904T3 (en)
WO (1) WO1994011522A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK50699A3 (en) * 1996-10-18 2000-05-16 Canji Inc Methods and compositions for delivery and expression of interferon-'alpha' nucleic acids
DE19860602A1 (en) * 1998-12-29 2000-07-06 Max Delbrueck Centrum Gene transfer vector for the diagnosis and therapy of malignant tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339654C (en) * 1988-06-03 1998-02-03 Ursula A. Germann Gene therapy using gene fusion for genetic or acquired disorders

Also Published As

Publication number Publication date
EP0670904A1 (en) 1995-09-13
EP0670904B1 (en) 2003-03-19
WO1994011522A3 (en) 1994-09-29
DE4238778C2 (en) 1995-11-02
JPH09504161A (en) 1997-04-28
DE59310334D1 (en) 2003-04-24
DE4238778A1 (en) 1994-05-19
ATE234929T1 (en) 2003-04-15
WO1994011522A2 (en) 1994-05-26

Similar Documents

Publication Publication Date Title
FI951404A0 (en) Adenovirus vectors to transmit foreign genes to the central nervous system, especially the brain, cells
ES2127831T3 (en) MULTICISTRONIC EXPRESSION UNITS AND THEIR APPLICATION.
DE69114299D1 (en) METHOD AND COMPOSITIONS FOR GENE THERAPY AND STRENGTHENING THE IMMUNE SYSTEM.
SE8004066L (en) PLASMIDES, THEIR PREPARATION, THEIR USE AS VECTORS, THEREFORE RECEIVED CELLS AND THEIR USE
NO981353L (en) Regulated genes and uses thereof
AU1955388A (en) Method for potentiating and inhibiting insulin-like growth factor activity
DK0719343T3 (en) Adeno-associated viral (AAV) liposomes and method associated therewith
DK0939763T3 (en) Controlled shift-mediated DNA recombination
FI855141A7 (en) Recombinant DNA vectors capable of expressing apoaequorin.
DE69830663D1 (en) NON-PRIMATED LENTIVIRAL VECTORS AND PACKAGING SYSTEMS
NO990086L (en) Abbreviated, deleterious type I and type II tumor necrosis factor receptors
DK1222298T3 (en) Vectors and methods for recombinant protein expression
DK0832258T3 (en) Upstream activator sequences and recombinant promoter sequences that are functional in Yarrowia and vectors containing these
WO1997022695A3 (en) Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
FI961666A7 (en) Gene therapy for restenosis using an adenovirus vector
FI961202A0 (en) The Grb3-3 gene, its variants and their uses
DE69838681D1 (en) ESCHERICHIA COLI HIGH EXPRESSION VECTOR
DE69830910D1 (en) KALIUM CHANNEL PROTEINS FOR USE IN GENE THERAPY TO REDUCE ECG DYSFUNCTION
DK0670904T3 (en) Vector for expression of therapeutically relevant genes
DK0817858T3 (en) Vectors containing therapeutic genes for antimicrobial peptides for use in gene therapy
ES2113948T3 (en) YEAST PROMOTER AND ITS USE.
ES8800985A1 (en) Cloning or expression vectors containing the genome of avian Erythroblastosis virus and cells transfected by these vectors.
DE59913022D1 (en) SELF-DELETING VECTORS FOR CANCER THERAPY
DK0781344T3 (en) Newly known implant and novel vector for the treatment of acquired diseases
DE59510829D1 (en) GENE THERAPEUTIC METHOD USING DNA VECTORS WITHOUT SELECTION MARKER GENE